Posted on February 12, 20212/12/21
NICE Draft Guidance Rejects Zynteglo for Transfusion-dependent Beta-thalassaemia
Posted on February 12, 20212/12/21
EC Commits Aspen to Reducing Off-patent Cancer Meds by 73% Following Investigation
Posted on February 11, 20212/11/21
WHO Backs AZ Vaccine Amid Concerns, Supports Longer Dosing Schedule
Posted on February 10, 20212/10/21
EU Finalizes Agreement for Extra 300M Pfizer COVID-19 Vaccines
Posted on February 9, 20212/9/21
PhRMA Report Sheds Light on How Hospital Practices Increase Costs for Employers, Patients
Posted on February 8, 20212/8/21
G-BA Proposes RWE Scheme for Zolgensma Use in Germany
Posted on February 5, 20212/5/21
Lombardy’s Next Tender: A Big Opportunity for Name-Brand and Generic Drugmakers Alike
Posted on February 4, 20212/4/21
EC Publishes ‘Europe’s Beating Cancer Plan’ Detailing 4 Key Areas for Action
Posted on February 3, 20212/3/21
KPBMA Wants South Korea to be Self-Sufficient, Pharmaceutical Powerhouse
Posted on February 2, 20212/2/21